The increasing prevalence of Parkinson’s disease, rising healthcare expenditure, and technological advancements in drug ...

Cerevel Therapeutics, which AbbVie is acquiring, said Thursday its drug tavapadon, taken with the common Parkinson's drug ...

After 17 years of serving his country, Mark Kelm of Minnesota is now providing a different type of service: advocating for ...

Levodopa is the most efficacious agent for the treatment of motor features of Parkinson's disease but its chronic use is associated with the development of motor complications. Mounting evidence ...

The global Parkinson’s Disease market is projected to be valued US$ 3.7 billion. The global market is anticipated to expand ...

A student team in the Department of Biomedical Engineering has developed a signal processing algorithm that they hope will ...

Lucknow: Challenging one’s brain is one of the most effective ways to stay away from Parkinson’s disease, according to ...

Dopa-decarboxylase inhibitor + dopamine precursor. ≥18yrs: Do not crush or chew. Patients not receiving levodopa: initially one Sinemet CR 50–200 tab twice daily, at intervals of at least 6 hrs.

Michael J. Fox posed for photographs alongside his wife Tracy Pollan on the red carpet at the glitzy Time 100 Gala in New ...

Good morning and thank you for standing by. Welcome to the AbbVie first quarter 2024 earnings conference call. All ...

In fluctuating PD patients, treatment with Stalevo® prolongs the clinical effects of levodopa and reduces variability of levodopa plasma levels, thereby resulting in increased 'on' time and ...